CLINICAL ROLE -
HEALTHY DIET MAY DECREASE RISK OF VTE
Read More
FISH OIL/WARFARIN COMBINATION MAY INCREASE BLEEDING RISK
AAICH RATE INCREASING
WARFARIN SENSITIVITY DNA TEST LAUNCHED
DOES ASPIRIN USE AFFECT ICH OUTCOME?
TEST HELPS PREDICT RISK OF RECURRENT VTE
PLAN NOW FOR DVT AWARENESS MONTH
DRUG-ELUTING STENTS MAY POSE CLOTTING RISK
CLOTS UNLIKELY TO MIGRATE AFTER 5 TO10 DAYS
GENERIC WARFARIN A SAFE SUBSTITUTE
TIPS FOR MANAGING NOSEBLEEDS
ASPIRIN UNDER STUDY FOR ANTICANCER EFFECTS
ASPIRIN AS EFFECTIVE AS ENOXAPARIN FOR PREVENTION OF RECURRENT MISCARRIAGE
ATRIAL FIBRILLATION GUIDELINES UPDATED
WARFARIN/ASPIRIN COMBINATION IN PAD INCREASES BLEEDING RISK
SMOKING WEAKENS ANTICLOTTING EFFECT OF ASPIRIN
Patients Should be Chosen Wisely for Newer Treatments
FDA ISSUES WARNING REGARDING BIRTH CONTROL PATCH
COMBINED ANTITHROMBOTIC THERAPY INCREASES RISK OF GI BLEEDING
NEW CASES OF AF RISING DRAMATICALLY
ELDERLY PEOPLE ON CHRONIC LOW-DOSE ASPIRIN LESS LIKELY TO BE ANEMIC
IDENTIFYING PATIENTS AT RISK FOR RECURRENT VTE
USE OF ASPIRIN AND IBUPROFEN
FIXED-DOSE HEPARIN EFFECTIVE IN VTE TREATMENT
RESOURCES AVAILABLE FOR PATIENTS WITH CLOTTING DISORDERS
TIAs: WHAT TO DO WHEN ASPIRIN IS NOT ENOUGH
Exercise and Diabetes: ADA Issues New Guidelines
AMERICAN HEART ASSOCIATION ISSUES NEW STROKE-PREVENTION GUIDELINES
WARFARIN THERAPY SUPERIOR TO CLOPIDOGREL/ASPIRIN IN AF
CRANBERRY/WARFARIN INTERACTION REVISITED
